{
  "trial_id": "NCT01722266",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "type 1 diabetes mellitus",
      "label": "met",
      "evidence": "molecular analysis"
    },
    {
      "criterion": "insulin therapy for more than 12 months",
      "label": "met",
      "evidence": "70/30 Insulin"
    },
    {
      "criterion": "HbA1c of less than 8.5%",
      "label": "met",
      "evidence": "6.5%"
    },
    {
      "criterion": "age 18-75 years",
      "label": "met",
      "evidence": "25-year-old man"
    }
  ],
  "exclusion": [
    {
      "criterion": "randomized to receive subcutaneous injection daily of Liraglutide or placebo",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "study medication in blinded form",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has type 1 diabetes and is on insulin therapy. He meets the inclusion criteria but does not meet the exclusion criteria.",
  "_meta": {
    "topic_id": "65",
    "trial_id": "NCT01722266",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}